SHANGHAI, March 31, 2016 /PRNewswire/ -- Hosted by UBM China & CPhI China, the world's largest pharmaceutical APIs expo, and co-organized by Shanghai's Pudong Financial Services Association of Science and Technology, Nextgen2016 will run from April 12-13 in Ballroom 3F of the New World Shanghai Hotel.
According to the China Food and Drug Administration (CFDA), there are many policy and regulatiory changes coming this year. These will influence the entire generics industry chain in terms of generics application, quality improvement, clinical data requirements and internationalization.
The conference will focus on the theme, "How to understand new government initiatives and overcome fierce competition in a new policy environment?" Conference organizers have gathered 18 speakers with relevant experience and expertise to offer their insights into the changes coming to the industry. Speakers such as Drug Examination Experts from the CFDA, Institute of Materia Medica, Chinese Academy of Medical Sciences, R&D-Based Pharmaceutical Association Committee (RDPAC), Huahai Pharmaceutical Co., Ltd, Perrigo China & Research Institute of Simcere, will deliver addresses. Download the full list of the speakers.
Topic & Speaker Highlights
1. The most anticipated pilot policies and regulations
2. How to win in a market that is in transition
3. How to establish advantages amidst technology, research and development barriers?
So far more than 50 companies and 80 delegates have registered to attend the conference, such as Changzhou Siyao Pharm, Livzon, Ninhua Group, Sanofi, AUPA, Nuokang Biopharma, Merro Pharmaceutical, BEILU Pharmaceutical, Wanhua, Shenzhen Zhijun Pharmaceutical, Eisai, Novartis and Pfizer.
For further information, please contact:
Ms. Julia Zhu
+86-21-61573922
julia.zhu@ubm.com
